Legal Representation
Attorney
Christine M. Baker
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 28, 2026 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 26, 2026 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 26, 2026 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 26, 2026 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 12, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 12, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 12, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 3, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 15, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 15, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and veterinary preparations, namely, nano particles to improve delivery of plasmid DNA and messenger RNA molecules for vaccines, oncology vaccines, oncology therapeutics, immunotherapy and drug resistance; nano particles, nano spheres, nano shells, hollow nano particles and hollow nano spheres, for the delivery of pharmaceutical or veterinary agents and preparations; hollow nano spheres containing nucleic acids for medical or veterinary purposes; nano particles, nano spheres, nano shells, hollow nano particles, hollow nano spheres, nano shells for the delivery of pesticides, herbicides and fungicides; nano particles for drug delivery
Class 042
Research and development services relating to nano particles, nano spheres and nano shells for drug delivery; research and development services relating to nano particles, nano spheres and nano shells containing nucleic acids for drug delivery; pharmaceutical services, namely, research and development of pharmaceutical drugs utilizing nano particles to improve delivery of plasmid DNA and messenger RNA molecules for oncology vaccines and oncology therapeutics; information, advisory and consultancy services relating to the aforesaid
Classification
International Classes
005
042